Caveolin-1, when expressed by fibroblasts, appears to negatively regulate tumour cell growth and the loss of expression is strongly correlated with reduced overall survival, tamoxifen resistance and metastasis in breast cancer [4, 5] and high Gleason score in prostate cancer [6]. The gene discussed is CAV1; the disease is neoplasm.